SMTL ID : 5kz0.1

Structure of Human Anaplastic Lymphoma Kinase in Complex With 2-[(1R)-1-{[2-amino-5-(1,3-dimethyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluoro-N,N-dimethylbenzamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.30 Å
Oligo State
monomer
Ligands
1 x 6YL: 2-[(1~{R})-1-[2-azanyl-5-(1,3-dimethylpyrazol-4-yl)pyridin-3-yl]oxyethyl]-4-fluoranyl-~{N},~{N}-dimethyl-benzamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Johnson, T.W. et al., Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations. J. Med. Chem. (2014)
Release Date
2016-08-17
Peptides
ALK tyrosine kinase receptor: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence

2xp2.1 | 4ccb.1 | 4ccu.1 | 4cli.1 | 4cmo.1 | 4cmt.1 | 4cmu.1 | 4cnh.1 | 4cnh.2 | 4ctb.1 | 4ctc.1 | 5imx.1 | 6cdt.1